Previous results of our group have identified several compounds which are indeed capable of restoring PANK2 expression levels and improving pathophysiological alterations in fibroblasts derived from PKAN patients [10, 14, 18]. This evidence concerns the gene PANK2 and pantothenate kinase-associated neurodegeneration.